Benoit Chabot mainly focuses on RNA splicing, Molecular biology, Alternative splicing, Exon and Exonic splicing enhancer. His studies in RNA splicing integrate themes in fields like Ribonucleoprotein, RNA-binding protein, Binding site and Cell biology. In his study, HeLa, Programmed cell death and Telomere is strongly linked to RNA, which falls under the umbrella field of Cell biology.
His study in Molecular biology is interdisciplinary in nature, drawing from both Mutant, Locus and snRNP. The Alternative splicing study combines topics in areas such as Computational biology and Gene expression. His work focuses on many connections between Exonic splicing enhancer and other disciplines, such as RNA interference, that overlap with his field of interest in TAF9, Cell culture, Apoptosis and Immunology.
His primary areas of study are RNA splicing, Alternative splicing, Molecular biology, Cell biology and Exon. His RNA splicing research incorporates elements of RNA-binding protein, Intron and splice. His Alternative splicing research is multidisciplinary, relying on both Cancer research and Computational biology.
The concepts of his Molecular biology study are interwoven with issues in Ribonucleoprotein, Small nuclear ribonucleoprotein, snRNP, RNA polymerase II and Binding site. His Cell biology study incorporates themes from Heterogeneous Nuclear Ribonucleoprotein A1, RNA, RNA interference, Telomerase and Telomere. His studies deal with areas such as Protein splicing and Post-transcriptional modification as well as Exonic splicing enhancer.
His primary areas of investigation include Alternative splicing, RNA splicing, RNA-binding protein, Cell biology and Exon. His work carried out in the field of Alternative splicing brings together such families of science as Cancer research, DNA damage and DNA repair. His study in RNA splicing is interdisciplinary in nature, drawing from both Computational biology and Intron.
His RNA-binding protein study combines topics from a wide range of disciplines, such as Molecular biology and Gene knockdown. His Molecular biology research integrates issues from Transcription factor II F, Response element, RNA polymerase II, Transcription and Transcription factor II D. His Cell biology research is multidisciplinary, incorporating perspectives in Heterogeneous Nuclear Ribonucleoprotein A1, RNA, Mutation, Amyotrophic lateral sclerosis and DNA-binding protein.
The scientist’s investigation covers issues in RNA splicing, Alternative splicing, RNA-binding protein, Cell biology and Intron. Genetics covers Benoit Chabot research in Alternative splicing. As part of his studies on RNA-binding protein, he often connects relevant subjects like Molecular biology.
His studies in Molecular biology integrate themes in fields like Three prime untranslated region, Messenger RNA, Untranslated region, SR protein and Regulation of gene expression. His study looks at the relationship between Cell biology and topics such as Exon, which overlap with Amyotrophic lateral sclerosis. His Intron course of study focuses on Precursor mRNA and Progeria, splice and Senescence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.
Benoit Chabot;Dennis A. Stephenson;Verne M. Chapman;Peter Besmer.
Nature (1988)
U2 as well as U1 small nuclear ribonucleoproteins are involved in premessenger RNA splicing
Douglas L. Black;Benoit Chabot;Joan A. Steitz.
Cell (1985)
Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.
K Nocka;S Majumder;B Chabot;P Ray.
Genes & Development (1989)
Systematic Analysis of the Protein Interaction Network for the Human Transcription Machinery Reveals the Identity of the 7SK Capping Enzyme
Célia Jeronimo;Diane Forget;Annie Bouchard;Qintong Li.
Molecular Cell (2007)
hnRNP proteins and splicing control.
Rebeca Martinez-Contreras;Philippe Cloutier;Lulzim Shkreta;Jean-Francois Fisette.
Advances in Experimental Medicine and Biology (2007)
Cancer-associated regulation of alternative splicing.
Julian P Venables;Roscoe Klinck;ChuShin Koh;Julien Gervais-Bird.
Nature Structural & Molecular Biology (2009)
A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding.
A Lavigueur;H La Branche;A R Kornblihtt;B Chabot.
Genes & Development (1993)
Control of alternative splicing through siRNA-mediated transcriptional gene silencing.
Mariano Alló;Valeria Buggiano;Juan P Fededa;Ezequiel Petrillo.
Nature Structural & Molecular Biology (2009)
Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase
Hélène LaBranche;Sophie Dupuis;Yaacov Ben-David;Maria Rosa Bani.
Nature Genetics (1998)
The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein.
Benoit Chabot;Douglas L. Black;David M. LeMaster;Joan A. Steitz.
Science (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université de Sherbrooke
University of Montpellier
Yale University
University of Liège
McGill University
University of Liège
University of Michigan–Ann Arbor
Global HIV Vaccine Enterprise
Inserm
Memorial Sloan Kettering Cancer Center
International Centre for Genetic Engineering and Biotechnology
Publications: 31
Zhejiang University
London School of Economics and Political Science
Peking University
University of Konstanz
Spanish National Research Council
University of Florida
University of Queensland
North Carolina State University
University of Stirling
Duke University
Massey University
University of California, San Diego
University of Surrey
University of Florida
Technical University of Madrid
Edge Hill University